

Better Care with Diagnostics You Can Count On
Bionote, an animal health diagnostics company, gives veterinarians the power to practice medicine how they’ve always wanted. Bionote’s flagship Vcheck F line of quantitative, in-clinic analyzers – including the popular Vcheck V200 analyzer - and biomarker tests for canine, feline and equine medicine quickly provide veterinarians with the answers they need at the point of care. The Vcheck F line provides the largest quantitative europium immunoassay menu available in the world, including patent-pending NT-proBNP and Troponin I.
​
At Bionote, we continuously strive to expand our product offerings, maintaining our mission of technologically advancing the industry and supplying veterinarians with the tools they need for the best possible standard of patient care. We believe that veterinarians should have the freedom and flexibility to practice medicine without cost and time barriers. Bionote’s model helps facilitate this approach practically and affordably. Recent additions to Bionote’s product line include a rapid one-step Canine Heartworm testing kit; the Vcheck H analyzer, which tests for 35 different parameters in four blood cell types; the Vcheck C for simultaneous, efficient and highly accurate analysis of biochemistry, electrolytes, coagulation and more with a small blood sample; and the Vcheck U, an analyzer that performs chemistry and sediment testing on urine samples. Through rapid growth, our commitment to providing reliable diagnostics remains.
Bionote Timeline
2016
Bionote Korea launches Vcheck series, an Immunofluorescence Analyzer for Veterinary use
2021
Cumulative Global Vcheck Sales Reach Surpasses 11,000 units (#1 Best-Selling Fluorescent Immunoassay Analyzer)
2022
Canine and Feline Troponin are added to Bionote USA Vcheck line (Becomes the only manufacturer in the veterinary marketplace to offer fully-quantitative Troponin I for both species)
2019
Bionote USA was established
2021
Feline NT-proBNP is added to Bionote USA’s NT-proBNP line (Becomes the only manufacturer in the veterinary marketplace to offer in-clinic, fully-quantitative NT-proBNP for both species)
2023
Bionote USA launches Vcheck Equine products (Progesterone, SAA and IgG)
2024
Rapid Canine Heartworm is added to Bionote USA’s product offerings